Assessing the readiness of hospitals in Riyadh Province for efficient and timely stroke management: A pilot study

References

1. 1.↵
   World Health Organization. The top 10 causes of death. 9 December 2020. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
2. 2.↵
   1. El-Hajj M,
   2. Salameh P,
   3. Rachidi S,
   4. Hosseini H.

   The epidemiology of stroke in the Middle East. Eur Stroke J 2016; 1: 180–198.

   OpenUrl
3. 3.↵
   1. Jan MM,
   2. Qari FA.

   Epidemiology of stroke in Saudi Arabia. Saudi Med J 2001; 22: 375–376.

   OpenUrlFREE Full Text
4. 4.↵
   1. Al-Senani F,
   2. Al-Johani M,
   3. Salawati M,
   4. Alhazzani A,
   5. Morgenstern LB,
   6. Seguel Ravest V, et al.

   An epidemiological model for first stroke in Saudi Arabia. J Stroke Cerebrovasc Dis 2020; 29: 104465.

   OpenUrl
5. 5.↵
   1. Powers WJ,
   2. Rabinstein AA,
   3. Ackerson T,
   4. Adeoye OM,
   5. Bambakidis NC,
   6. Becker K, et al.

   2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018; 49: e46–e110.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Baatiema L,
   2. Otim M,
   3. Mnatzaganian G,
   4. Aikins AD,
   5. Coombes J,
   6. Somerset S.

   Towards best practice in acute stroke care in Ghana: a survey of hospital services. BMC Health Serv Res 2017; 17: 108.

   OpenUrlPubMed
7. 7.↵
   1. Kim JT,
   2. Fonarow GC,
   3. Smith EE,
   4. Reeves MJ,
   5. Navalkele DD,
   6. Grotta JC, et al.

   Treatment with tissue plasminogen activator in the golden hour and the shape of the 4.5-hour time-benefit curve in the national United States get with the guidelines-stroke population. Circulation 2017; 135: 128–139.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Masjuan J,
   2. Gállego Culleré J,
   3. Ignacio García E,
   4. Mira Solves JJ,
   5. Ollero Ortiz A,
   6. Vidal de Francisco D, et al.

   Stroke treatment outcomes in hospitals with and without Stroke Units. Neurologia 2020; 35: 16–23.

   OpenUrl
9. 9.↵
   1. Al-Senani F,
   2. Al-Johani M,
   3. Salawati M,
   4. ElSheikh S,
   5. AlQahtani M,
   6. Muthana J, et al.

   A national economic and clinical model for ischemic stroke care development in Saudi Arabia: a call for change. Int J Stroke 2019; 14: 835–842.

   OpenUrl
10. 10.↵
    1. Jeon SB,
    2. Ryoo SM,
    3. Lee DH,
    4. Kwon SU,
    5. Jang S,
    6. Lee EJ, et al.

    Multidisciplinary approach to decrease in-hospital delay for stroke thrombolysis. J Stroke 2017; 19: 196–204.

    OpenUrl
11. 11.↵
    Stroke Foundation. Clinical guidelines for stroke management. Melbourne Australia, 2017. Available from: https://informme.org.au/Guidelines/Clinical-Guidelines-for-Stroke-Management. Accessed October 30, 2020
12. 12.↵
    1. Xian Y,
    2. Xu H,
    3. Lytle B,
    4. Blevins J,
    5. Peterson ED,
    6. Hernandez AF, et al.

    Use of strategies to improve door-to-needle times with tissue-type plasminogen activator in acute ischemic stroke in clinical practice: findings from target: Stroke. Circ Cardiovasc Qual Outcomes 2017; 10: e003227.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Hsieh MJ,
    2. Tang SC,
    3. Chiang WC,
    4. Tsai LK,
    5. Jeng JS,
    6. Ma MH.

    Effect of prehospital notification on acute stroke care: a multicenter study. Scand J Trauma Resusc Emerg Med 2016; 24: 57.

    OpenUrlPubMed
14. 14.↵
    1. Miura S,
    2. Miyata R,
    3. Matsumoto S,
    4. Higashi T,
    5. Wakisaka Y,
    6. Ago T, et al.

    Quality management program of stroke rehabilitation using adherence to guidelines: a nationwide initiative in Japan. J Stroke Cerebrovasc Dis 2019; 28: 2434–2441.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Hartford W,
    2. Lear S,
    3. Nimmon L.

    Stroke survivors’ experiences of team support along their recovery continuum. BMC Health Serv Res 2019; 19: 723.

    OpenUrl